Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Current pharmaceutical design

• Publication date

  2001-01-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1381612013398248PMID 11311111
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.

  2000cited by this paper
• Leukotrien A4 hydrolase and the committed step in leukotriene B4 biosynthesis

  1999cited by this paper
• Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice.

  1999cited by this paper
• Analysis of the Molecular Mechanism of Substrate-mediated Inactivation of Leukotriene A4 Hydrolase*

  1998cited by this paper
• Involvement of leukotriene B4 in murine dermatitis models.

  1998cited by this paper
• Inhibitory effect of amphotericin B on leukotriene B4 synthesis in human neutrophils in vitro.

  1998cited by this paper
• Effects of SA6541, a leukotriene A4 hydrolase inhibitor, and indomethacin on carrageenan-induced murine dermatitis.

  1998cited by this paper
• Significance of leukotriene-A4 hydrolase in the pathogenesis of psoriasis.

  1997cited by this paper
• LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin

  1996cited by this paper
• Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.

  1996cited by this paper
• Leukotriene A4 Hydrolase, Mutation of Tyrosine 378 Allows Conversion of Leukotriene A4 into an Isomer of Leukotriene B4*

  1996cited by this paper
• The PPARalpha-leukotriene B4 pathway to inflammation control.

  1996cited by this paper
• Leukotriene A4 hydrolase: protection from mechanism-based inactivation by mutation of tyrosine-378.

  1996cited by this paper
• Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus.

  1996cited by this paper
• Modulators of leukotriene biosynthesis and receptor activation.

  1996cited by this paper
• Effects of metalloproteinase inhibitors on leukotriene A4 hydrolase in human airway epithelial cells.

  1995cited by this paper
• Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.

  1995cited by this paper
• Lipid mediators, free fatty acids and psoriasis.

  1995cited by this paper
• Amino hydroxamic acids as potent inhibitors of leukotriene A4 hydrolase.

  1995cited by this paper
• Investigation of the inhibition of leukotriene A4 hydrolase.

  1995cited by this paper
• Evidence for a catalytic role of tyrosine 383 in the peptidase reaction of leukotriene A4 hydrolase.

  1995cited by this paper
• 5-Lipoxygenase-activating protein (FLAP).

  1995cited by this paper
• Modulation of pulmonary leukotriene formation and perfusion pressure by bestatin, an inhibitor of leukotriene A4 hydrolase.

  1994cited by this paper
• The Role of Leukotrienes in Inflammation

  1994cited by this paper
• Transcellular biosynthesis of leukotrienes and lipoxins via leukotriene A4 transfer.

  1993cited by this paper
• High-level expression and purification of human leukotriene A4 hydrolase from insect cells infected with a baculovirus vector.

  1993cited by this paper
• Bestatin inhibits covalent coupling of [3H]LTA4 to human leukocyte LTA4hydrolase

  1992cited by this paper
• Omega-[(omega-arylalkyl)aryl]alkanoic acids: a new class of specific LTA4 hydrolase inhibitors.

  1992cited by this paper
• Leukotriene A4 hydrolase: abrogation of the peptidase activity by mutation of glutamic acid-296.

  1992cited by this paper
• Leukotriene A4 hydrolase: determination of the three zinc-binding ligands by site-directed mutagenesis and zinc analysis.

  1991cited by this paper
• Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes.

  1991cited by this paper
• Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril.

  1991cited by this paper
• Leukotriene B4 in inflammation.

  1990cited by this paper
• Mechanism-based inactivation of leukotriene A4 hydrolase during leukotriene B4 formation by human erythrocytes.

  1990cited by this paper
• Zinc coordination, function, and structure of zinc enzymes and other proteins.

  1990cited by this paper
• Leukotriene A4 hydrolase: an epoxide hydrolase with peptidase activity.

  1990cited by this paper
• Leukotriene A4 hydrolase: a zinc metalloenzyme.

  1990cited by this paper
• Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases.

  1990cited by this paper
• Leukotriene A4 hydrolase is a zinc-containing aminopeptidase.

  1990cited by this paper
• Molecular evolution and zinc ion binding motif of leukotriene A4 hydrolase.

  1990cited by this paper
• Leukotriene A4 hydrolase: analysis of some human tissues by radioimmunoassay.

  1989cited by this paper
• Leukotriene A4 hydrolase activity of human airway epithelial cells.

  1989cited by this paper
• Leukotriene A4, conversion to leukotriene B4 in human T-cell lines.

  1988cited by this paper
• Molecular cloning and amino acid sequence of leukotriene A4 hydrolase.

  1987cited by this paper
• Stimulation of interleukin 2 and interferon gamma production by leukotriene B4 in human lymphocyte cultures.

  1986cited by this paper
• Neutrophil LTA4 hydrolases and leukotriene B4 receptors: effects of leukotriene epoxides and their enzymatic products.

  1986cited by this paper
• Leukotrienes in inflammation

  1986cited by this paper
• Tissue distribution of leukotriene A4 hydrolase activity in guinea pig.

  1986cited by this paper
• Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolase.

  1985cited by this paper
• Leukotriene A5 is a substrate and an inhibitor of rat and human neutrophil LTA4 hydrolase.

  1985cited by this paper
• Differential effects of leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions.

  1985cited by this paper
• Enzymatic hydration of leukotriene A4. Purification and characterization of a novel epoxide hydrolase from human erythrocytes.

  1985cited by this paper
• Leukotrienes augment interleukin 1 production by human monocytes.

  1985cited by this paper
• Sputum leukotrienes in obstructive airways diseases.

  1984cited by this paper
• Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

  1984cited by this paper
• The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin.

  1984cited by this paper
• Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes.

  1984cited by this paper
• LEUKOTRIENE B4, AN INFLAMMATORY MEDIATOR IN GOUT

  1982cited by this paper
• Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.

  1980cited by this paper

• Optical Control of Leukotriene A4 Hydrolase Using Photoswitchable Inhibitors.

  2025cites this paper
• Compilation and Evaluation of Fatty Acid Mimetics Screening Library.

  2022cites this paper
• Structures of Leukotriene Biosynthetic Enzymes and Development of New Therapeutics.

  2022cites this paper
• Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking

  2020cites this paper
• 5-Lipoxygenase (ALOX5): Genetic susceptibility to type 2 diabetes and vitamin D effects on monocytes.

  2019cites this paper
• Neutrophils in Tissue Trauma of the Skin, Bone, and Lung: Two Sides of the Same Coin

  2018cites this paper
• Leukotriene biosynthetic enzymes as therapeutic targets.

  2018cites this paper
• 5-Lipoxygenase: Its involvement in gastrointestinal malignancies.

  2018cites this paper
• Lipid Peroxidation, Diet, and the Genotoxicology of Aging

  2016cites this paper
• Quantitative structure activity relationship and binding investigation of N-alkyl glycine amides as inhibitors of Leukotriene A4 hydrolase

  2015cites this paper
• Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation.

  2015cites this paper
• Identification, characterization and evaluation of novel leukotriene biosynthesis inhibitors

  2014cites this paper
• Targeting leukotriene B4 in inflammation

  2014cites this paper
• Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors

  2013influential citation
• A sensitive fluorigenic substrate for selective in vitro and in vivo assay of leukotriene A4 hydrolase activity.

  2013cites this paper
• Hydroxamate, a key pharmacophore exhibiting a wide range of biological activities.

  2013cites this paper
• Design and synthesis of tubulin-binding agents, and their incorporation into novel dual-acting hybrid molecules targeting the tumour vasculature

  2013cites this paper
• The leukotrienes: immune-modulating lipid mediators of disease.

  2012cites this paper
• A metabonomic approach to the effect evaluation of treatment in patients infected with influenza A (H1N1).

  2012cites this paper
• Chemical genetic approaches for elucidating protease function and drug-target potential in Plasmodium falciparum

  2012cites this paper
• Engagement of the S1, S1' and S2' subsites drives efficient catalysis of peptide bond hydrolysis by the M1-family aminopeptidase from Plasmodium falciparum.

  2012cites this paper
• Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design

  2012cites this paper
• Leukotriene A4 Hydrolase – An Evolving Therapeutic Target

  2012cites this paper
• Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney

  2011cites this paper
• Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease.

  2011cites this paper
• Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.

  2010cites this paper
• Hydroxamic Acids: Biological Properties and Potential Uses as Therapeutic Agents

  2010cites this paper
• Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer.

  2009cites this paper
• [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase.

  2009cites this paper
• Inhibitors of the 5-lipoxygenase pathway in atherosclerosis.

  2009cites this paper
• Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase.

  2009cites this paper
• Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.

  2008cites this paper
• Cif Is Negatively Regulated by the TetR Family Repressor CifR

  2008cites this paper
• Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives.

  2008cites this paper
• Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase.

  2008cites this paper
• Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.

  2008cites this paper
• Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.

  2008cites this paper
• Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.

  2008cites this paper
• Mechanisms of intimal hyperplasia learned from a murine carotid artery ligation model.

  2008cites this paper
• Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase

  2008cites this paper
• Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors.

  2008cites this paper
• Development of bestatin-based activity-based probes for metallo-aminopeptidases.

  2008cites this paper
• Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.

  2008cites this paper
• Current status of leukotriene A4 hydrolase inhibitors

  2008cites this paper
• Asthma and Chronic Obstructive Pulmonary Disease

  2007cites this paper
• Inhibition of 5-Lipoxygenase Product Synthesis by Natural Compounds of Plant Origin

  2007cites this paper
• Development of a Homogeneous Time-Resolved Fluorescence Leukotriene B4 Assay for Determining the Activity of Leukotriene A4 Hydrolase

  2007influential citation
• The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field

  2007cites this paper
• The potential of Triptolide as effective topical anti-inflammatory agent

  2007cites this paper
• Anti-Inflammatory Activity of a Potent, Selective Leukotriene A4 Hydrolase Inhibitor in Comparison with the 5-Lipoxygenase Inhibitor Zileuton

  2007cites this paper
• CARDIOVASCULAR DISEASES

  2006cites this paper
• Inhibiteurs hétérocycliques de lta4h substitués par biaryle pour le traitement des inflammations

  2006cites this paper
• Inhibiteurs hétérocycliques substitués par biaryle de lta4h pour le traitement d'inflammations

  2006cites this paper
• Epoxide hydrolases: their roles and interactions with lipid metabolism.

  2005cites this paper
• Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases.

  2004cites this paper
• Leukotriene A4 hydrolase as a target for cancer prevention and therapy.

  2004cites this paper
• Matrix metalloproteinases: a therapeutic target in cardiovascular disease.

  2003cites this paper
• Nonpeptidic chymase inhibitors: design and structure-activity relationships of pyrimidinone derivatives based on the predicted binding mode of a peptidic inhibitor.

  2003cites this paper
• Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase.

  2003cites this paper
• Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis.

  2003cites this paper
• Design of beta-turn based therapeutic agents.

  2003cites this paper
• Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin.

  2003cites this paper
• Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists.

  2003cites this paper
• Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.

  2002cites this paper
• Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.

  2002cites this paper
• Multiple activities in lantibiotics--models for the design of novel antibiotics?

  2002cites this paper
• Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.

  2002cites this paper
• Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.

  2002cites this paper
• Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight‐binding inhibitors

  2002cites this paper